O
Omid C. Farokhzad
Researcher at Brigham and Women's Hospital
Publications - 340
Citations - 75194
Omid C. Farokhzad is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Drug delivery & Aptamer. The author has an hindex of 110, co-authored 329 publications receiving 64226 citations. Previous affiliations of Omid C. Farokhzad include Beth Israel Deaconess Medical Center & Columbia University.
Papers
More filters
Journal ArticleDOI
Engineering of Mature Human Induced Pluripotent Stem Cell‐Derived Cardiomyocytes Using Substrates with Multiscale Topography
Parisa Pour Shahid Saeed Abadi,Parisa Pour Shahid Saeed Abadi,Jessica C. Garbern,Jessica C. Garbern,Shahed Behzadi,Michael J. Hill,Jason S. Tresback,Tiam Heydari,Mohammad Reza Ejtehadi,Nafis Ahmed,Elizabeth Copley,Haniyeh Aghaverdi,Richard T. Lee,Richard T. Lee,Omid C. Farokhzad,Morteza Mahmoudi +15 more
TL;DR: Polydimethylsiloxane substrates with 3D topography at the micrometer and sub‐micrometer levels are developed and used as cell‐culture substrates and show that the physico‐mechanical cues generated by these 3D‐patterned substrates improve the phenotype of the CMs via the reorganization of the cytoskeletal network and the regulation of chromatin conformation.
Patent
Nanostructured Gels Capable of Controlled Release of Encapsulated Agents
Jeffrey M. Karp,Praveen Kumar Vemula,Nathaniel R. Campbell,Abdullah Muhammad Syed,Sufeng Zhang,Omid C. Farokhzad,Robert S. Langer +6 more
TL;DR: In this article, self-assembled gel compositions including a gelator, e.g., an enzyme-cleavable gelator having a molecular weight of 2500 or less, are described.
Journal ArticleDOI
Identification of cell-specific and developmentally regulated nuclear factors that direct myeloid and lymphoid expression of the CD11a gene
TL;DR: The promoter region of the CD11a gene is cloned and characterized and localized cis-acting elements involved in its expression in lymphoid and myeloid cells are characterized, suggesting that MS-2, a noncovalently associated heterodimeric receptor, may play a major role in regulating myeloids gene expression.
Patent
IMMUNONANOTHERAPEUTICS THAT PROVIDE IgG HUMORAL RESPONSE WITHOUT T-CELL ANTIGEN
Matteo Iannacone,Frank Alexis,Pamela Basto,Elliott Ashley Moseman,Jinjun Shi,Robert Langer,Omid C. Farokhzad,Ulrich H. von Andrian,Elena Tonti +8 more
TL;DR: In this paper, the authors provide compositions and systems for delivery of nanocarriers to cells of the immune system, which elicits an immune system response in the form of antibody production, wherein the nanoccarriers lack any T cell antigens.
Journal ArticleDOI
Emerging Advances in Nanotheranostics with Intelligent Bioresponsive Systems.
TL;DR: Intelligent nanotheranostics based on bioresponsive systems have recently emerged and offer the promise of high specificity and efficiency via “on-demand” activation of both therapeutic and diagnostic capabilities.